title: The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue.
abstract: Side effects or toxicities are frequent, undesirable companions of almost all forms of non-surgical cancer therapy. It is unusual for patients to complete treatment with radiation or chemotherapy without experiencing at least one form of therapy-associated tissue injury or systemic side effect. Often, toxicities do not occur as solitary events; rather, they result in clusters of symptoms that share a common biological aetiology. Like any disease, cancer treatment-related toxicities (CTRTs) vary in their severity. But, in contrast to most diseases in which incidence is described as being present or absent, the current approach to CTRT typically limits reporting to severe cases only. Not only does this dilute the frequency with which CTRTs occur, but it also undermines our ability to determine the full burden of their impact and to accurately assess the cost effectiveness of potential toxicity interventions. In this article, we report the results of a directed literature review for the years 2000-2012, in which we studied and compared three tissue-based toxicities (nausea and vomiting, diarrhoea, and oral mucositis) and one systemic toxicity (fatigue). Our results confirm the heavy burden of resource use and cost associated with CTRTs. The inclusion of fatigue in our analysis provided an opportunity to compare and contrast a toxicity in which there are both acute and chronic consequences. Our findings also demonstrate a number of challenges to, and opportunities for, future study. Among the most obvious are the lack of provider consistency in diagnosis and grading, especially when there is no global agreement on severity scales. Compounding this inconsistency is the disconnect between healthcare providers and patients that exists when describing toxicity severity and impact. In many cases, cancer can be thought of as a chronic disease that requires prolonged but episodic treatment once the acute disease is eradicated. This change reflects increasing treatment successes, but it also implies that the burden of CTRTs will be expanded and prolonged. Creation of hierarchical attribution of costs in the presence of simultaneous CTRTs, accurate coding, and consistent tracking tools for toxicities will be imperative for effective appraisal of the costs associated with cancer treatment regimen toxicities.
authors: Harvard School of Dental Medicine, Boston, MA, USA.
authors: Alan
authors: A
authors: Carlotto
authors: Virginia L
authors: VL
authors: Hogsett
authors: Elyse M
authors: EM
authors: Maiorini
authors: Janet G
authors: JG
authors: Razulis
authors: Stephen T
authors: ST
authors: Sonis
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000191:economics; D003967:Diarrhea / Q000139:chemically induced / Q000191:economics*; D005221:Fatigue / Q000139:chemically induced / Q000191:economics*; D017048:Health Care Costs; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000191:economics*; D009369:Neoplasms / Q000188:drug therapy / Q000191:economics / Q000532:radiotherapy; D011878:Radiotherapy / Q000009:adverse effects* / Q000191:economics; D013280:Stomatitis / Q000139:chemically induced / Q000191:economics*; D014839:Vomiting / Q000139:chemically induced / Q000191:economics*
chemical_list: D000970:Antineoplastic Agents
references: Support Care Cancer. 2005 May;13(5):318-24
references: 15614493
references: J Pain Symptom Manage. 2009 Apr;37(4):715-36
references: 19019626
references: Oncol Nurs Forum. 2007 Jul;34(4):827-34
references: 17723983
references: Support Care Cancer. 2011 Jan;19(1):131-40
references: 20101417
references: J Clin Oncol. 2001 Apr 15;19(8):2201-5
references: 11304772
references: Oncol Nurs Forum. 2006 May 03;33(3):593-601
references: 16676015
references: Support Care Cancer. 2007 Jan;15(1):31-8
references: 16788840
references: Support Care Cancer. 2011 Sep;19(9):1421-7
references: 20694564
references: Curr Opin Support Palliat Care. 2009 Mar;3(1):50-4
references: 19365161
references: Eur J Cancer. 2007 Jan;43(2):299-307
references: 17134890
references: Support Care Cancer. 2011 Jun;19(6):843-51
references: 20532923
references: Can J Gastroenterol. 2005 Feb;19(2):83-7
references: 15729427
references: J Pain Symptom Manage. 2009 Oct;38(4):522-32
references: 19608377
references: Support Care Cancer. 2000 Jul;8(4):323-33
references: 10923774
references: Support Care Cancer. 2011 Jul;19(7):963-9
references: 20499108
references: Ann Oncol. 2012 Aug;23(8):1986-1992
references: 22396444
references: J Natl Cancer Inst. 2011 Jan 19;103(2):117-28
references: 21228314
references: Support Cancer Ther. 2005 Apr 1;2(3):181-7
references: 18628170
references: Support Care Cancer. 2004 Apr;12(4):219-26
references: 14767748
references: Cancer. 2003 Oct 1;98(7):1531-9
references: 14508842
references: J Med Econ. 2011;14(1):87-98
references: 21241160
references: Cancer. 2008 Sep 15;113(6):1446-52
references: 18683883
references: J Eval Clin Pract. 2012 Aug;18(4):753-60
references: 21414113
references: Support Care Cancer. 2013 Feb;21(2):397-404
references: 22722887
references: J Natl Cancer Inst. 2006 Aug 16;98(16):1108-17
references: 16912263
references: Oncologist. 2000;5(3):250-9
references: 10884503
references: Curr Oncol. 2010 Feb;17(1):7-16
references: 20179798
references: J Natl Cancer Inst Monogr. 2001;(29):45-51
references: 11694566
references: Support Care Cancer. 2013 Jun;21(6):1665-75
references: 23338228
references: J Clin Oncol. 2004 Sep 1;22(17):3485-90
references: 15337796
references: Br J Cancer. 2001 Feb 2;84(3):313-20
references: 11161394
references: Oncologist. 2000;5(5):353-60
references: 11040270
references: Support Care Cancer. 2012 Apr;20(4):813-20
references: 21472498
references: Ann Oncol. 2004 Mar;15(3):526-36
references: 14998860
references: J Cancer Surviv. 2008 Dec;2(4):296-302
references: 19003541
references: Radiother Oncol. 2003 Mar;66(3):253-62
references: 12742264
references: Br J Cancer. 2008 Feb 26;98(4):708-15
references: 18283298
references: Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1110-20
references: 17398022
references: Cancer. 2007 Aug 1;110(3):678-85
references: 17567835